Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration

Area of Science:

• Gerontology
• Cellular Biology
• Molecular Biology

Background:

• Cellular senescence, a state of irreversible growth arrest, is linked to aging and age-related diseases.
• Inhibitors of mechanistic target of rapamycin (mTOR), phosphatidylinositol 3-kinase (PI-3K), and mitogen-activated protein kinase kinase (MEK) pathways are known to regulate cell growth and proliferation.

Purpose of the Study:

• To review and synthesize findings from three reports on the suppression of cellular senescence using specific pathway inhibitors.
• To investigate the mechanistic link between growth inhibition and the suppression of senescence.
• To explore the potential of these senescence-inhibiting drugs as interventions to decelerate organismal aging.

Main Methods:

• Overview of existing research and data from three independent studies.
• Analysis of the effects of mTOR, PI-3K, and MEK inhibitors on cellular senescence markers.
• Conceptual re-evaluation of aging processes in light of senescence suppression.

Main Results:

• Inhibitors of mTOR, PI-3K, and MEK pathways demonstrate the capacity to suppress cellular senescence.
• The suppression of senescence by growth inhibitors suggests a complex interplay between growth regulation and aging phenotypes.
• The findings necessitate a broader discussion on the definition and hallmarks of aging.

Conclusions:

• Targeting key growth regulatory pathways with specific inhibitors offers a potential strategy for mitigating cellular senescence.
• The ability of these inhibitors to suppress senescence raises significant questions about their potential to impact organismal aging.
• A revised understanding of aging may be required to fully appreciate the implications of senescence suppression therapies.